{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:55:35Z","timestamp":1667980535843},"reference-count":56,"publisher":"Japan Society for Clinical Immunology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2177\/jsci.35.470","type":"journal-article","created":{"date-parts":[[2012,12,30]],"date-time":"2012-12-30T22:33:06Z","timestamp":1356906786000},"page":"470-480","source":"Crossref","is-referenced-by-count":8,"title":["Accelerated atherosclerosis and inflammation in systemic lupus erythematosus"],"prefix":"10.2177","volume":"35","author":[{"given":"Yu","family":"FUNAKUBO ASANUMA","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381016"},{"key":"2","unstructured":"2) Aranow C, Ginzler EM. : Epidemiology of cardiovascular disease in systemic lupus erythematosus. <i>Lupus<\/i> <b>9<\/b> : 166-169, 2000 ; Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studied in systemic lupus erythematosus. Results from a single center. I. Cause of death. <i>J Rheumatol<\/i>. <b>22<\/b> : 1259-1264, 1995."},{"key":"3","unstructured":"4) Nossent J, et al. : Current causes of death in systemic lupus erythematosus in Europe, 2000-2004 : relation to disease activity and damage accrual. <i>Lupus<\/i>. <b>16<\/b> : 309-317, 2007."},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1002\/art.24537"},{"key":"5","unstructured":"6) Manzi S, et al. : Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus : comparison with the Framingham Study. <i>Am J Epidemiol<\/i>. <b>145<\/b> : 408-415, 1997."},{"key":"6","unstructured":"7) Benqtsson C, et al. : Cardiovascular event in systemic lupus erythematosus in northern Sweden : incidence and predictors in a 7-year follow-up study. <i>Lupus<\/i>. <b>21<\/b> : 452-459, 2012."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I"},{"key":"8","unstructured":"9) Asanuma Y, et al. : Premature coronary-artery atherosclerosis in systemic lupus erythematosus. <i>N Engl J Med<\/i>. <b>349<\/b> : 2307-2315, 2003."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035471"},{"key":"10","unstructured":"11) Kiani AN, Magder LS, Petri M. : Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity. <i>J Rheumatol<\/i>. <b>35<\/b> : 1300-1306, 2008."},{"key":"11","unstructured":"12) Kiani AN, et al. : Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus. <i>Rheumatology<\/i>. <b>50<\/b> : 2071-2079, 2011."},{"key":"12","unstructured":"13) Bruce IN, et al. : Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. <i>J Rheumatol<\/i>. <b>27<\/b> : 2372-2377, 2000."},{"key":"13","unstructured":"14) Nikpour M, et al. : Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. <i>J Rheumatol<\/i>. <b>36<\/b> : 288-294, 2009."},{"key":"14","unstructured":"15) Symmons DP, Gabriel SE. : Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. <i>Nat Rev Rheumatol<\/i>. <b>7<\/b> : 399-408, 2011."},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90578-Y"},{"key":"16","unstructured":"17) Manzi S, et al. : Age-specific incidence rates of myocardial infarction and angina in women with Systemic Lupus Erythematosus : comparison with the Framingham study. <i>Am J Epidimiol<\/i>. <b>145<\/b> : 408-415, 1997."},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1002\/art.20622"},{"key":"18","unstructured":"19) Urowitz MB, et al. : Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythrmatosus. <i>Arthritis Care Res<\/i>. <b>62<\/b> : 881-887, 2010."},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309104862"},{"key":"20","unstructured":"21) Urowitz MB, Ibanez D, Gladman DD. : Atherosclerotic vascular events in a single large lupus cohort : prevalence and risk factors. <i>J Rheumatol<\/i>. <b>34<\/b> : 329-354, 2007."},{"key":"21","unstructured":"22) Chung CP, et al. : Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. <i>J Rheumatol<\/i>. <b>34<\/b> : 1849-1854, 2007."},{"key":"22","unstructured":"23) Bruce IN, et al. : Natural history of hypercholesterolemia in systemic lupus erythematosus. <i>J Rheumatol<\/i>. <b>26<\/b> : 2137-4317, 1999."},{"key":"23","unstructured":"24) Kawai S, Mizushima Y, Kaburaki J. : Increased serum lipoprotein(a) levels in systemic lupus erythematosus with myocardial and cerebral infarctions. <i>J Rheumatol<\/i>. <b>22<\/b> : 1210-1211, 1995."},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(75)90575-6"},{"key":"25","unstructured":"27) Bulkley BH, Klacsmann PG, Hutchins GM. : Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries : a clinicopathologic study of 9 patients with progressive systemic sclerosis. <i>Am Heart J<\/i>. <b>59<\/b> : 563-569, 1978."},{"key":"26","doi-asserted-by":"crossref","unstructured":"28) Asanuma Y, Kawai S : Apolipoprotein(a) deposition in atherosclerotic coronary arteries of a patient with systemic lupus erythematosus : comment on the article by Romero et al. <i>Arthritis rheum<\/i>. <b>43<\/b> : 2141-2142, 2000.","DOI":"10.1002\/1529-0131(200009)43:9<2141::AID-ANR29>3.0.CO;2-2"},{"key":"27","unstructured":"29) Chung CP, et al. : High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus : association with disease characteristics and cardiovascular risk factors. <i>Ann Rheum Dis<\/i>. <b>66<\/b> : 208-214, 2007."},{"key":"28","unstructured":"30) Chung CP, et al. : Inflammation-associated insulin resistance. Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. <i>Arthritis rheum<\/i>. <b>58<\/b> : 2105-1218, 2008."},{"key":"29","unstructured":"31) Ross R. : Atherosclerosis&mdash;an inflammatory disease. <i>N Engl J Med<\/i> <b>340<\/b> : 115-124, 1999."},{"key":"30","unstructured":"32) Kao AH, Sabatine JM, Manzi S. : Update on vascular disease in systemic lupus erythematosus. <i>Curr Opin Rheumatol<\/i>. <b>15<\/b> : 519-527, 2003."},{"key":"31","unstructured":"33) Erbel C, et al. : Functional profile of activated dendritic cells in unstable atherosclerotic plaque. <i>Basic Res Cardiol<\/i>. <b>102<\/b> : 123-132, 2007."},{"key":"32","unstructured":"34) Von Feldt JM, et al. : Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. <i>Arthritis rheum<\/i>. <b>54<\/b> : 2220-2227, 2006."},{"key":"33","unstructured":"35) Karp I, et al. : Recent corticosteroid use and recent disease activity : independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? <i>Arthritis rheum<\/i>. <b>59<\/b> : 169-175, 2008."},{"key":"34","unstructured":"36) Asanuma Y, et al. : Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus : relationship to cardiovascular risk factors. <i>J Rheumatol<\/i>. <b>33<\/b> : 539-545, 2006."},{"key":"35","unstructured":"39) Skaggs BJ, Hahn BH, McMahon M. : Accelerated atherosclerosis in patients with SLE-mechanisms and management. <i>Nat Rev Rheumatol<\/i>. <b>8<\/b> : 214-223, 2012."},{"key":"36","unstructured":"40) Sturfelt G, et al. : Anti-cardiolipin antibodies in patients with systemic lupus erythematosus. <i>Arthritis rheum<\/i>. <b>30<\/b> : 382-388, 1987."},{"key":"37","unstructured":"41) Boey ML, et al. : Thrombosis in systemic lupus erythematosus : striking association with the presence of circulating lupus anticoagulant. <i>Br Med J<\/i>. <b>287<\/b> : 1021-1023, 1983."},{"key":"38","unstructured":"42) Harris EN, et al. : Anticardiolipin antibodies : detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. <i>Luncet<\/i>. <b>2<\/b> : 1211-1214, 1983."},{"key":"39","unstructured":"43) Nicolo D, Monestier M. : Antiphospholipid antibodies and atherosclerosis. <i>Clinical Immunology<\/i>. <b>112<\/b> : 183-189, 2004."},{"key":"40","unstructured":"44) Nicolo D, Goldman BI, Monestier M. : Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody. <i>Arthritis rheum<\/i>. <b>48<\/b> : 2974-2978, 2003."},{"key":"41","unstructured":"45) Farzaneh-Far A, et al. : Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. <i>Arthritis rheum<\/i>. <b>54<\/b> : 3918-3925, 2006."},{"key":"42","unstructured":"46) Fesmire J, Wolfson-Reichlin M, Reichlin M. : Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus. <i>Rev Bras Reumatol<\/i>. <b>50<\/b> : 539-551, 2010."},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678920262"},{"key":"44","unstructured":"48) Petri M, et al. : Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus : a longitudinal data analysis. <i>Am J Med<\/i>. <b>96<\/b> : 254-259, 1994."},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90578-Y"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1002\/art.20622"},{"key":"47","unstructured":"53) Schanberg LE, et al. : Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. : Premature atherosclerosis in pediatric systemic lupus erythematosus : risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. <i>Arthritis rheum<\/i>. <b>60<\/b> : 1496-1507, 2009."},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000039169.47943.EE"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200207272"},{"key":"50","unstructured":"58) Amuro H, et al. : Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. <i>Arthritis rheum<\/i>. 2073-2085, 2010."},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16449-0"},{"key":"52","unstructured":"61) Plazak W, et al. : Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients : a prospective, randomized, double-masked, placebo-controlled study. <i>Arthritis Res Ther<\/i>. <b>13<\/b> : R117, 2011."},{"key":"53","unstructured":"63) Marks D, et al. : A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. <i>Atherosclerosis<\/i>. <b>168<\/b> : 1-14, 2003."},{"key":"54","unstructured":"64) Elliott JR, Manzi S. : Cardiovascular risk assessment and treatment in systemic lupus erthematosus. <i>Best Pract Res Clin Rheumatol<\/i>. <b>23<\/b> : 481-494, 2009."},{"key":"55","unstructured":"66) Nikpour M, et al. : Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus : a prospective proof-of-concept cohort study. <i>Arthritis Res Ther<\/i>. <b>13<\/b> : R156, 2011."},{"key":"56","unstructured":"67) Mok CC, et al. : Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus : a randomized, double-blind, placebo-controlled trial. <i>Arthritis Care Res<\/i>. <b>63<\/b> : 875-883, 2011."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/6\/35_470\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:51:25Z","timestamp":1621486285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/6\/35_470\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.35.470","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}